0001437749-24-020851.txt : 20240620
0001437749-24-020851.hdr.sgml : 20240620
20240620180753
ACCESSION NUMBER: 0001437749-24-020851
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240617
FILED AS OF DATE: 20240620
DATE AS OF CHANGE: 20240620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lonial Sagar
CENTRAL INDEX KEY: 0001816609
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32639
FILM NUMBER: 241057751
MAIL ADDRESS:
STREET 1: C/O TG THERAPEUTICS, INC.
STREET 2: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TG THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001001316
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 363898269
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: (212) 554-4484
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
FORMER COMPANY:
FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030310
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC
DATE OF NAME CHANGE: 20000330
FORMER COMPANY:
FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960703
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-06-17
0001001316
TG THERAPEUTICS, INC.
TGTX
0001816609
Lonial Sagar
3020 CARRINGTON MILL BLVD, SUITE 475
MORRISVILLE
NC
27560
1
0
Common Stock
2024-06-17
4
S
0
9585
16.39
D
99293
D
Common Stock
2024-06-19
4
A
0
22250
0
A
121543
D
Common Stock
2024-06-20
4
S
0
16348
16.87
D
105195
D
These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Lonial's income tax obligations.
Includes shares of restricted Common Stock, which vest over various time periods.
Reflects a grant of restricted shares that will vest on June 14, 2025.
/s/ Sagar Lonial
2024-06-20